Stemline, a Menarini Group Company is committed to making difference in cancer patients’ lives. We invest in developing precision medicine through our pipeline of investigational drugs. Partnering with cancer experts and research institutions globally, we aim to improve our outstanding of cancer to enable personalized care from early detection to precision medicine.